<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>796</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11602571</PubmedId>
            <Abstract>Antigen three-dimensional structure potentially limits the access of endoproteolytic processing enzymes to cleavage sites and of class II major histocompatibility antigen-presenting proteins to helper T-cell epitopes. Helper T-cell epitopes in bacteriophage T4 Hsp10 have been mapped by restimulation of splenocytes from CBA/J and C57BL/6J mice immunized in conjunction with mutant (R192G) heat-labile enterotoxin from Escherichia coli. Promiscuously immunogenic sequences were associated with unstable loops in the three-dimensional structure of T4 Hsp10. The immunodominant sequence lies on the N-terminal flank of the 22-residue mobile loop, which is sensitive to proteolysis in divergent Hsp10s. Several mobile loop deletions that inhibited proteolysis in vitro caused global changes in the helper T-cell epitope map. A mobile loop deletion that strongly stabilized the protein dramatically reduced the immunogenicity of the flanking immunodominant helper T-cell epitope, although the protein retained good overall immunogenicity. Antisera against the mobile loop deletion variants exhibited increased cross-reactivity, most especially the antisera against the strongly stabilized variant. The results support the hypothesis that unstable loops promote the presentation of flanking epitopes and suggest that loop deletion could be a general strategy to increase the breadth and strength of an immune response.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>161-8</ArticlePages>
            <ArticleTitle>Structural basis for helper T-cell and antibody epitope immunodominance in bacteriophage T4 Hsp10. Role of disordered loops.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Dai</LastName>
                    <ForeName>Guixiang</ForeName>
                </Author>
                <Author>
                    <LastName>Carmicle</LastName>
                    <ForeName>Stephanie</ForeName>
                </Author>
                <Author>
                    <LastName>Steede</LastName>
                    <ForeName>N Kalaya</ForeName>
                </Author>
                <Author>
                    <LastName>Landry</LastName>
                    <ForeName>Samuel J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Biochemistry, Tulane University Health Sciences Center, New Orleans, Louisiana 70112-2699, USA.</Affiliations>
            <ArticleChemicalList>Chaperonin 10;Epitopes, T-Lymphocyte;Immunodominant Epitopes</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Bacteriophage T4(chemistry); Chaperonin 10(chemistry; immunology); Epitope Mapping; Epitopes, T-Lymphocyte; Female; Immunodominant Epitopes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Molecular Sequence Data; T-Lymphocytes, Helper-Inducer(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>277</Volume>
                <Issue>1</Issue>
                <Title>The Journal of biological chemistry</Title>
                <Issn>1083-351X</Issn>
                <MedlineTa>J Biol Chem</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MSEVQQLPIRAVGEY</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>15</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>42548</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>15</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide doesn't induce proliferation of T cells from source protein immunized mice, but some stimulation is seen in mobile loop deletion variants of source protein immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8509</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSEVQQLPIRAVGEY</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>15</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8C (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>1</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSEVQQLPIRAVGEY</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>15</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to the epitope, suggests that this peptide gains immunogenicity following mobile loop deletion C-ter. Other loop deletion variants did not augment immunogenicity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8378</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>1</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSEVQQLPIRAVGEY</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>15</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QLPIRAVGEYVILVS</LinearSequence>
                        <StartingPosition>6</StartingPosition>
                        <EndingPosition>20</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>51465</EpitopeId>
                <ReferenceStartingPosition>6</ReferenceStartingPosition>
                <ReferenceEndingPosition>20</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide does not induce proliferation of T cells from source protein immunized mice, but some stimulation is seen in mobile loop deletion variants of source protein immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8476</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QLPIRAVGEYVILVS</LinearSequence>
                                            <StartingPosition>6</StartingPosition>
                                            <EndingPosition>20</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QLPIRAVGEYVILVS</LinearSequence>
                                        <StartingPosition>6</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope implies it gains immunogenicity upon mobile loop reduction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8508</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QLPIRAVGEYVILVS</LinearSequence>
                                            <StartingPosition>6</StartingPosition>
                                            <EndingPosition>20</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8C (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QLPIRAVGEYVILVS</LinearSequence>
                                        <StartingPosition>6</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>40</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope implies it gains immunogenicity following mobile loop size reduction, while a shorter version (T4Hsp10d8) did not increase immunogenicity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8382</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QLPIRAVGEYVILVS</LinearSequence>
                                        <StartingPosition>6</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVGEYVILVSEPAQA</LinearSequence>
                        <StartingPosition>11</StartingPosition>
                        <EndingPosition>25</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>5340</EpitopeId>
                <ReferenceStartingPosition>11</ReferenceStartingPosition>
                <ReferenceEndingPosition>25</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide does not induce proliferation of T cells from source protein immunized mice, but some stimulation is seen in mobile loop deletion variants of source protein immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8385</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVGEYVILVSEPAQA</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>25</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8384</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>3</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVGEYVILVSEPAQA</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>25</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8478</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVGEYVILVSEPAQA</LinearSequence>
                                            <StartingPosition>11</StartingPosition>
                                            <EndingPosition>25</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>3</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVGEYVILVSEPAQA</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>25</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>40</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to the epitope suggests that this peptide gains immunogenicity following mobile loop size reduction. A longer version (T4Hsp120LIG) did not augment the immunogenicity of this epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8479</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVGEYVILVSEPAQA</LinearSequence>
                                            <StartingPosition>11</StartingPosition>
                                            <EndingPosition>25</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8C (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>3</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVGEYVILVSEPAQA</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>25</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to the peptide suggests that this peptide gains immunogenicity following mobile loop size reduction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                        <StartingPosition>16</StartingPosition>
                        <EndingPosition>30</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>69039</EpitopeId>
                <ReferenceStartingPosition>16</ReferenceStartingPosition>
                <ReferenceEndingPosition>30</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the immunodominant region of source protein, adjacent to the mobile loop. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8387</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                                        <StartingPosition>16</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8401</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                                            <StartingPosition>16</StartingPosition>
                                            <EndingPosition>30</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8C (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                                        <StartingPosition>16</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Diminished T cell proliferation in response to this peptide in mice immunized with the mobile loop deletion variant suggests the mutation affects immunogenicity. This correlates with the diminished protease sensitivity of this variant compared to the wild type protein.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8386</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                                        <StartingPosition>16</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>80</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope in two strains of mice implies there is no strong MHC II restriction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8736</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>168</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                                        <StartingPosition>16</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>80</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope in two strains of mice implies there is no strong MHC II restriction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8400</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                                            <StartingPosition>16</StartingPosition>
                                            <EndingPosition>30</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VILVSEPAQAGDEEV</LinearSequence>
                                        <StartingPosition>16</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>80</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide retains immunogenicity. This correlates with the similar protease sensitivity of this variant and the wild type protein.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPAQAGDEEVTESGL</LinearSequence>
                        <StartingPosition>21</StartingPosition>
                        <EndingPosition>35</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>13617</EpitopeId>
                <ReferenceStartingPosition>21</ReferenceStartingPosition>
                <ReferenceEndingPosition>35</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the immunodominant region of source protein, in the mobile loop. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8397</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPAQAGDEEVTESGL</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>35</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8737</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>168</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>5</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPAQAGDEEVTESGL</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>35</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope in two strains of mice implies there is no strong MHC II restriction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8396</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>5</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPAQAGDEEVTESGL</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>35</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>40</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope in two strains of mice implies there is no strong MHC II restriction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GDEEVTESGLIIGKR</LinearSequence>
                        <StartingPosition>26</StartingPosition>
                        <EndingPosition>40</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>18962</EpitopeId>
                <ReferenceStartingPosition>26</ReferenceStartingPosition>
                <ReferenceEndingPosition>40</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the immunodominant region of source protein, in the mobile loop. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8403</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Sera reactivity to this peptide reflects its immunogenicity and is related to its position in the mobile loop of the source protein.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDEEVTESGLIIGKR</LinearSequence>
                                        <StartingPosition>26</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8402</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>168</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDEEVTESGLIIGKR</LinearSequence>
                                        <StartingPosition>26</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>40</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to the epitope was observed in C57BL/6J mice, but not in CBA/J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TESGLIIGKRVQGEV</LinearSequence>
                        <StartingPosition>31</StartingPosition>
                        <EndingPosition>45</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>63525</EpitopeId>
                <ReferenceStartingPosition>31</ReferenceStartingPosition>
                <ReferenceEndingPosition>45</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the immunodominant region of source protein, in the mobile loop. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8405</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>Sera reactivity to this peptide reflects its immunogenicity and is related to its position in the mobile loop of the source protein.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TESGLIIGKRVQGEV</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>45</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8404</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>168</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>7</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TESGLIIGKRVQGEV</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>45</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope was seen in C57BL/6J mice, but not in CBA/J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IIGKRVQGEVPELCV</LinearSequence>
                        <StartingPosition>36</StartingPosition>
                        <EndingPosition>50</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>26503</EpitopeId>
                <ReferenceStartingPosition>36</ReferenceStartingPosition>
                <ReferenceEndingPosition>50</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the immunodominant region of source protein, in the mobile loop. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8407</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IIGKRVQGEVPELCV</LinearSequence>
                                        <StartingPosition>36</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8406</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>8</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IIGKRVQGEVPELCV</LinearSequence>
                                        <StartingPosition>36</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>60</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this epitope was seen in CBA/J mice, but not in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VQGEVPELCVVHSVG</LinearSequence>
                        <StartingPosition>41</StartingPosition>
                        <EndingPosition>55</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>70559</EpitopeId>
                <ReferenceStartingPosition>41</ReferenceStartingPosition>
                <ReferenceEndingPosition>55</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide rests partly in the immunodominant region of source protein, and is adjacent to the mobile loop. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8409</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VQGEVPELCVVHSVG</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>55</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8410</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VQGEVPELCVVHSVG</LinearSequence>
                                            <StartingPosition>41</StartingPosition>
                                            <EndingPosition>55</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>9</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VQGEVPELCVVHSVG</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>55</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>60</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to this peptide was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide retains immunogenicity, although the results were not clear cut.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8408</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>9</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VQGEVPELCVVHSVG</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>55</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation in response to the epitope is observed inconsistantly in CBA/J mice (SI&gt;4).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PELCVVHSVGPDVPE</LinearSequence>
                        <StartingPosition>46</StartingPosition>
                        <EndingPosition>60</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>47340</EpitopeId>
                <ReferenceStartingPosition>46</ReferenceStartingPosition>
                <ReferenceEndingPosition>60</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope doesn’t induce proliferation of T cells from source protein-immunized mice. It corresponds to the sequence just C-ter to mobile loop. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8413</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PELCVVHSVGPDVPE</LinearSequence>
                                        <StartingPosition>46</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8412</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>10</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PELCVVHSVGPDVPE</LinearSequence>
                                        <StartingPosition>46</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8414</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>PELCVVHSVGPDVPE</LinearSequence>
                                            <StartingPosition>46</StartingPosition>
                                            <EndingPosition>60</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>10</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PELCVVHSVGPDVPE</LinearSequence>
                                        <StartingPosition>46</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide gains immunogenicity upon reduction of the mobile loop size.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VHSVGPDVPEGFCEV</LinearSequence>
                        <StartingPosition>51</StartingPosition>
                        <EndingPosition>65</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>68889</EpitopeId>
                <ReferenceStartingPosition>51</ReferenceStartingPosition>
                <ReferenceEndingPosition>65</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the subdominant immunogenic region II of source protein, adjacent to the mobile loop. Upon main mobile loop reduction, this region gains some  immunogenicity. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8456</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>66.7</ResponseFrequency>
                            <AssayComments>This peptide is located in the roof β- hairpin with mobility and T cell immunogenicity (albeit subdominant).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VHSVGPDVPEGFCEV</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>65</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8506</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VHSVGPDVPEGFCEV</LinearSequence>
                                            <StartingPosition>51</StartingPosition>
                                            <EndingPosition>65</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8 (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>11</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VHSVGPDVPEGFCEV</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>65</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Diminished T cell proliferation in response to this peptide in mice immunized with the mobile loop deletion variant suggests the mutation affects immunogenicity. This correlates with the diminished protease sensitivity of this variant compared to the wild type protein. In mice immunized with an even more resistant mobile loop deletion variant, T4Hsp10d8C, no proliferation was observed.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8457</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VHSVGPDVPEGFCEV</LinearSequence>
                                            <StartingPosition>51</StartingPosition>
                                            <EndingPosition>65</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>11</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VHSVGPDVPEGFCEV</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>65</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>80</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide retains immunogenicity. This correlates with the similar protease sensitivity of this variant and the wild type protein.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8455</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>11</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VHSVGPDVPEGFCEV</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>65</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PDVPEGFCEVGDLTS</LinearSequence>
                        <StartingPosition>56</StartingPosition>
                        <EndingPosition>70</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>47218</EpitopeId>
                <ReferenceStartingPosition>56</ReferenceStartingPosition>
                <ReferenceEndingPosition>70</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the subdominant region II, and retains some immunogenicity in immunodominant loop deletion variants immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8460</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PDVPEGFCEVGDLTS</LinearSequence>
                                        <StartingPosition>56</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8462</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>PDVPEGFCEVGDLTS</LinearSequence>
                                            <StartingPosition>56</StartingPosition>
                                            <EndingPosition>70</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8 (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>12</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PDVPEGFCEVGDLTS</LinearSequence>
                                        <StartingPosition>56</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>60</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that reduction of the mobile loop size does not affect immunogenicity. A slight enhancement is actually seen, indicating this variant enhances subdominant epitope presentation. Nevertheless, a shorter mobile loop variant, T4Hsp10d8C failed to induce a response.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8461</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>PDVPEGFCEVGDLTS</LinearSequence>
                                            <StartingPosition>56</StartingPosition>
                                            <EndingPosition>70</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>12</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PDVPEGFCEVGDLTS</LinearSequence>
                                        <StartingPosition>56</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to this peptide was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide retains immunogenicity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8459</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>12</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PDVPEGFCEVGDLTS</LinearSequence>
                                        <StartingPosition>56</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Similar results were observed in C57BL/6J mice. Proliferation (SI&gt;4) in response to this epitope in both strains of mice implies there is no strong MHC II restriction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                        <StartingPosition>61</StartingPosition>
                        <EndingPosition>75</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>19505</EpitopeId>
                <ReferenceStartingPosition>61</ReferenceStartingPosition>
                <ReferenceEndingPosition>75</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is in the subdominant region II, and has enhanced  immunogenicity in immunodominant loop deletion variants immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8464</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>75</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8468</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                            <StartingPosition>61</StartingPosition>
                                            <EndingPosition>75</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8 (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>13</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>75</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope in mice immunized with the mobile loop deletion variant implies this peptide gains immunogenicity upon mobile loop reduction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8463</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>13</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>75</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8469</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                            <StartingPosition>61</StartingPosition>
                                            <EndingPosition>75</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8C (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>13</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>75</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope in mice immunized with the mobile loop deletion variant implies this peptide gains immunogenicity upon mobile loop reduction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8465</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                            <StartingPosition>61</StartingPosition>
                                            <EndingPosition>75</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>13</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GFCEVGDLTSLPVGQ</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>75</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>60</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope in mice immunized with the mobile loop deletion variant implies this peptide gains immunogenicity upon mobile loop reduction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>14</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GDLTSLPVGQIRNVP</LinearSequence>
                        <StartingPosition>66</StartingPosition>
                        <EndingPosition>80</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>19044</EpitopeId>
                <ReferenceStartingPosition>66</ReferenceStartingPosition>
                <ReferenceEndingPosition>80</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is not proliferative for T cells in source protein immunized mice, but some stimulation is seen in mobile loop deletion variants of source protein immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8471</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDLTSLPVGQIRNVP</LinearSequence>
                                        <StartingPosition>66</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8470</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>14</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDLTSLPVGQIRNVP</LinearSequence>
                                        <StartingPosition>66</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8472</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GDLTSLPVGQIRNVP</LinearSequence>
                                            <StartingPosition>66</StartingPosition>
                                            <EndingPosition>80</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>14</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDLTSLPVGQIRNVP</LinearSequence>
                                        <StartingPosition>66</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>40</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope in mice immunized with mobile loop deletion variant implies this peptide gains immunogenicity upon mobile loop reduction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8504</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GDLTSLPVGQIRNVP</LinearSequence>
                                            <StartingPosition>66</StartingPosition>
                                            <EndingPosition>80</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8C (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>14</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDLTSLPVGQIRNVP</LinearSequence>
                                        <StartingPosition>66</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide gains immunogenicity upon reduction of the mobile loop size. Another variant, T4Hsp10d8 did not have this effect, implying this peptide does not gain immunogenicity upon mobile loop reduction on both sides.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LPVGQIRNVPHPFVA</LinearSequence>
                        <StartingPosition>71</StartingPosition>
                        <EndingPosition>85</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>38753</EpitopeId>
                <ReferenceStartingPosition>71</ReferenceStartingPosition>
                <ReferenceEndingPosition>85</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is not proliferative for T cells in source protein immunized mice, but some stimulation is seen in mobile loop deletion variants of source protein immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8481</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>This peptide falls within a linear B cell epitopic region.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LPVGQIRNVPHPFVA</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>85</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8482</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LPVGQIRNVPHPFVA</LinearSequence>
                                            <StartingPosition>71</StartingPosition>
                                            <EndingPosition>85</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>15</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LPVGQIRNVPHPFVA</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>85</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>40</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide gains immunogenicity upon reduction of the mobile loop size, while shorter variants (T4Hsp10d8 &amp; T4Hsp10d8C) fail to show any effect.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8480</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>15</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LPVGQIRNVPHPFVA</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>85</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IRNVPHPFVALGLKQ</LinearSequence>
                        <StartingPosition>76</StartingPosition>
                        <EndingPosition>90</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>28350</EpitopeId>
                <ReferenceStartingPosition>76</ReferenceStartingPosition>
                <ReferenceEndingPosition>90</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is not proliferative for T cells in source protein immunized mice, but some stimulation is seen in mobile loop deletion variants of source protein immunized mice. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8485</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This peptide falls within a linear B cell epitopic region.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IRNVPHPFVALGLKQ</LinearSequence>
                                        <StartingPosition>76</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8484</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>16</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IRNVPHPFVALGLKQ</LinearSequence>
                                        <StartingPosition>76</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The lack of proliferation in response to this peptide was also observed in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8486</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IRNVPHPFVALGLKQ</LinearSequence>
                                            <StartingPosition>76</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8 (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>16</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IRNVPHPFVALGLKQ</LinearSequence>
                                        <StartingPosition>76</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide gains immunogenicity upon reduction of the mobile loop size, while other variants (T4Hsp10LIG and T4Hsp10d8C) fail to show any effect.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HPFVALGLKQPKEIK</LinearSequence>
                        <StartingPosition>81</StartingPosition>
                        <EndingPosition>95</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>24449</EpitopeId>
                <ReferenceStartingPosition>81</ReferenceStartingPosition>
                <ReferenceEndingPosition>95</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is not proliferative for T cells in source protein immunized CBA/J mice, but some stimulation is seen in C57BL/6J mice and in mobile loop deletion variants of source protein immunized CBA/J mice. It resides in the peripheral loop subdominant region III. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8488</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>This peptide falls within a linear B cell epitopic region.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HPFVALGLKQPKEIK</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>95</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8489</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HPFVALGLKQPKEIK</LinearSequence>
                                            <StartingPosition>81</StartingPosition>
                                            <EndingPosition>95</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8 (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>17</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HPFVALGLKQPKEIK</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>95</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide gains immunogenicity in CBA/J mice upon reduction of the mobile loop size, while other variants (T4Hsp10LIG and T4Hsp10d8C) fail to show any effect.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8487</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>168</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>17</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HPFVALGLKQPKEIK</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>95</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LGLKQPKEIKQKFVT</LinearSequence>
                        <StartingPosition>86</StartingPosition>
                        <EndingPosition>100</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>36204</EpitopeId>
                <ReferenceStartingPosition>86</ReferenceStartingPosition>
                <ReferenceEndingPosition>100</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is not proliferative for T cells in source protein immunized CBA/J mice, but some stimulation is seen in C57BL/6J mice and in mobile loop deletion variants of source protein immunized CBA/J mice. It resides in the peripheral loop subdominant region III. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8491</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LGLKQPKEIKQKFVT</LinearSequence>
                                        <StartingPosition>86</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8492</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LGLKQPKEIKQKFVT</LinearSequence>
                                            <StartingPosition>86</StartingPosition>
                                            <EndingPosition>100</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>18</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LGLKQPKEIKQKFVT</LinearSequence>
                                        <StartingPosition>86</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide gains immunogenicity upon reduction of the mobile loop size, while shorter variants (T4Hsp10d8 and T4Hsp10d8C) fail to show any effect.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8490</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>168</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>18</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LGLKQPKEIKQKFVT</LinearSequence>
                                        <StartingPosition>86</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>40</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this peptide was not seen in CBA/J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>19</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PKEIKQKFVTCHYKA</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>105</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>48050</EpitopeId>
                <ReferenceStartingPosition>91</ReferenceStartingPosition>
                <ReferenceEndingPosition>105</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is somehow proliferative for T cells in source protein or mobile loop deletion variants of source protein immunized CBA/J mice, but no stimulation is seen in C57BL/6J mice. It resides in the peripheral loop subdominant region III. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8494</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PKEIKQKFVTCHYKA</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>105</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8493</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>19</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PKEIKQKFVTCHYKA</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>105</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this peptide was not seen C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8495</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>PKEIKQKFVTCHYKA</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>105</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10d8 (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is deletion variant of source protein, with a shorter mobile loop. It was administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>19</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PKEIKQKFVTCHYKA</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>105</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>T cell proliferation (SI&gt;4) in response to the epitope was observed in mice immunized with the mobile loop deletion variant, suggesting that this peptide gains immunogenicity upon reduction of the mobile loop size, while other variants (T4Hsp10LIG and T4Hsp10d8C) fail to show any effect.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>20</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QKFVTCHYKAIPCLYK</LinearSequence>
                        <StartingPosition>96</StartingPosition>
                        <EndingPosition>111</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10665</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 8</LocationOfData>
                <EpitopeId>51187</EpitopeId>
                <ReferenceStartingPosition>96</ReferenceStartingPosition>
                <ReferenceEndingPosition>111</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide is somehow proliferative for T cells in source protein immunized CBA/J mice, but no stimulation is seen in C57BL/6J mice or in mobile loop deletion variants of source protein CBA/J immunized mice. It resides in the peripheral loop subdominant region III. Also known as Capsid assembly protein Gp31, head assembly cochaperone with GroEL.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8497</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QKFVTCHYKAIPCLYK</LinearSequence>
                                        <StartingPosition>96</StartingPosition>
                                        <EndingPosition>111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8496</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Hsp10</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>20</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QKFVTCHYKAIPCLYK</LinearSequence>
                                        <StartingPosition>96</StartingPosition>
                                        <EndingPosition>111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Proliferation (SI&gt;4) in response to this peptide was not seen in C57BL/6J mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>8498</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000236</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QKFVTCHYKAIPCLYK</LinearSequence>
                                            <StartingPosition>96</StartingPosition>
                                            <EndingPosition>111</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P17313.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10665</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>T4Hsp10LIG (deletion variant)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intranasal</Route>
                                <DoseSchedule>3 weekly immunizations with 20μg Immunogen in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunogen is a deletion variant of source protein, with a shorter mobile loop. They were administered in one nostril and 5μg Adjuvant (E. coli LT-R192G (mLT)) in PBS in the other nostril to preserve tertiary structure of source protein.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>121</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>20</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QKFVTCHYKAIPCLYK</LinearSequence>
                                        <StartingPosition>96</StartingPosition>
                                        <EndingPosition>111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P17313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10665</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>T cell proliferation was not observed in response to this epitope in mice immunized with the mobile loop deletion variant, suggesting this peptide does not gain immunogenicity upon mobile loop reduction. Similar results were seen with shorter variants, T4Hsp10d8 and T4Hsp10d8C.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

